17-09-2025 06:29 Home | Feedback | Sitemap| Careers | Contact Us |FAQ | Investor Complaints Data | Investor Charter Stock-Broker | Investor DP
  You Are On: EQUITY
Equity Analysis
Price
Gainers & Losers
Out & Under Performers
Only Buyers & Sellers
Advances & Declines
New Highs & Lows
Weightage
5 Day's Up & Down
Historical Returns
Volume
Analysis
News Analysis
Corporate Action
Corporate Info
Other Market
Share Holdings
Aurobindo Pharma Ltd.
 
BSE Code 524804
ISIN Demat INE406A01037
Book Value 363.17
NSE Code AUROPHARMA
Dividend Yield % 0.00
Market Cap 634206.33
P/E 32.08
EPS 34.04
Face Value 1  
Description ( As On June 2025 )No. of ShareHoldersNo. of Shares% of SharesDemat
Promoter          
  Indian Promoter  13  283115075  48.75  283115075  
  Foreign Promoter  1  17833646  3.07  17833646  
  Total Promoter  14  300948721  51.82  300948721  
          
Non Promoter          
 Institutions          
  Mutual Funds / UTI  37  110143159  18.96  110143159  
  FI/Bank/Insurance  25  31878720  5.49  31878720  
  Govt  1  26616    26616  
  FII          
  Other  661  97887403  16.85  97887403  
  Total Institutions  724  239935898  41.3  239935898  
 Non-Institution          
  Bodies Corporate  1537  2766130  0.48  2765020  
  Individuals          
  NRIs/OCBs  8776  2424511  0.42  2424511  
  Others  261157  34726363  5.97  34100291  
  Total Non-Institution  271470  39917004  6.87  39289822  
Total Non Promoter  272194  279852902  48.18  279225720  
          
  Depository Receipts          
          
Grand Total  272208  580801623  100  580174441  
 

Attention Investors : Prevent Unauthorised transactions in your account. Update your mobile numbers/email IDs with your stock brokers / DP and Exchanges / Depository. Receive information of your transactions directly from Exchanges / Depository on your mobile/email at the end of the day .......... Issued in the interest of investors

KYC is one time exercise while dealing in securities markets – once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.

“No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application from to authorize your bank to make payment in case of allotment. No worries for refund as the money remains in investor’s account.’

Registration granted by SEBI and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.